Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin

Bristol-Myers Squibb is launching Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin.

In general, the first-generation agents are primarily active against gram-positive bacteria. Second and third generations have increasing gram-negative coverage...sometimes at the expense of reduced gram-positive activity.

Fourth-generation cephalosporins are considered "broad spectrum" with both gram-negative and gram-positive coverage.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote